Chemical compound
- In general: ℞ (Prescription only)
Identifiers |
---|
|
CAS Number | |
---|
PubChem CID | |
---|
ChemSpider | |
---|
UNII | |
---|
ChEMBL | |
---|
CompTox Dashboard (EPA) | - DTXSID3046409
|
---|
Chemical and physical data |
---|
Formula | C14H19ClN2O2 |
---|
Molar mass | 282.77 g·mol−1 |
---|
3D model (JSmol) | |
---|
|
InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18) Key:YYFGRAGNYHYWEZ-UHFFFAOYSA-N |
Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol).[1] It is a non-competitive reversible inhibitor of monoamine oxidase A[2][3] that exhibits selective action on serotonin deamination.[4] Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.[5]
References
- ^ Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. p. 811. ISBN 978-0412466304.
- ^ Gol'dina OA, Moskvitina TA, Gankina EM, Kirkel' AZ, Kamyshanskaia NS, Lopatina KI, et al. (March 1991). "[The action of befol and its derivatives on monoamine oxidase of different origins]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 111 (3): 279–80. PMID 2054504.
- ^ Donskaya NS, Antonkina OA, Glukhan EN, Smirnov SK (2004-07-01). "Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine". Pharmaceutical Chemistry Journal. 0091-150X. 38 (7): 381–384. doi:10.1023/B:PHAC.0000048439.38383.5f. S2CID 29121452.
- ^ "Eprobemide". ChemIDplus.
- ^ "Befol". 4DOKTOR.RU Drug Information Handbook (in Russian). Retrieved 4 February 2014.
Specific reuptake inhibitors and/or receptor modulators |
---|
SSRIsTooltip Selective serotonin reuptake inhibitors | |
---|
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors | |
---|
NRIsTooltip Norepinephrine reuptake inhibitors | |
---|
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors | |
---|
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants | |
---|
SARIsTooltip Serotonin antagonist and reuptake inhibitors | |
---|
SMSTooltip Serotonin modulator and stimulators | |
---|
Others | |
---|
|
|
|
---|
TCAsTooltip Tricyclic antidepressants | |
---|
TeCAsTooltip Tetracyclic antidepressants | |
---|
Others | |
---|
|
|
|
---|
Non-selective | |
---|
MAOATooltip Monoamine oxidase A-selective | |
---|
MAOBTooltip Monoamine oxidase B-selective | |
---|
|
|
|
|
|
|
---|
Non-specific | AAADTooltip Aromatic L-amino acid decarboxylase | |
---|
MAOTooltip Monoamine oxidase | |
---|
|
---|
Phenethylamines (dopamine, epinephrine, norepinephrine) | PAHTooltip Phenylalanine hydroxylase | |
---|
THTooltip Tyrosine hydroxylase | - Substrates→Products: Tyrosine→L-DOPA (levodopa)
|
---|
DBHTooltip Dopamine beta-monooxygenase | |
---|
PNMTTooltip Phenylethanolamine N-methyltransferase | - Inhibitors: CGS-19281A
- SKF-64139
- SKF-7698
|
---|
COMTTooltip Catechol-O-methyl transferase | |
---|
|
---|
Tryptamines (serotonin, melatonin) | TPHTooltip Tryptophan hydroxylase | |
---|
AANATTooltip Serotonin N-acetyl transferase | |
---|
ASMTTooltip Acetylserotonin O-methyltransferase | |
---|
|
---|
Histamine | HDCTooltip Histidine decarboxylase | |
---|
HNMTTooltip Histamine N-methyltransferase | - Substrates→Products: Histamine→N-Methylhistamine
|
---|
DAOTooltip Diamine oxidase | - Substrates→Products: Histamine→Imidazole acetic acid
|
---|
|
---|
See also: Receptor/signaling modulators • Adrenergics • Dopaminergics • Melatonergics • Serotonergics • Monoamine reuptake inhibitors • Monoamine releasing agents • Monoamine neurotoxins |
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |